We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Image: Researchers identified blood-based genomic signatures characteristic of inflammatory breast cancer (photo courtesy of Shutterstock)

Liquid Biopsy Biomarkers Distinguish Inflammatory Breast Cancer and Support Monitoring

An enhanced RNA-sequencing method identifies biomarkers that distinguish inflammatory breast cancer, enabling liquid biopsy. More...
08 May 2026
Image: Small cell lung cancer is an aggressive malignancy that often responds to initial chemotherapy but commonly relapses, creating an urgent need for reliable resistance biomarkers (image credit: Shutterstock)

Biomarker Signals Chemotherapy Resistance in Relapsed Small Cell Lung Cancer

New findings identify a distinct treatment-resistant cell population as a post-therapy biomarker flagging chemotherapy-resistant relapsed SCLC. More...
08 May 2026
Image:The transaction is expected to close in the second half of 2026, with Roche paying USD 750 million upfront and up to USD 300 million in additional milestone payments

Roche to Acquire PathAI for Up to $1.05 Billion to Strengthen AI Diagnostics Portfolio

Roche entered an agreement to acquire PathAI for up to $1.05 billion, strengthening the AI capabilities of its Diagnostics division More...
08 May 2026
Image: The findings could enable noninvasive liquid biopsy profiling of the complex tumor microenvironment, helping guide precision oncology decisions across cancers and therapies (Photo credit: Shutterstock)

Blood Test Maps Tumor Microenvironment to Predict Immunotherapy Response

A first-of-its-kind blood test maps tumor ‘neighborhoods’ to improve prediction of immunotherapy benefit across cancers More...
08 May 2026
Image: The HemoSonics Quantra Hemostasis System provides comprehensive blood analysis, delivering rapid, real-time coagulation insights at the point of need. Quantra is the first and only cartridge-based, FDA-cleared viscoelastic testing (VET) platform for obstetrics. (Photo courtesy of HemoSonics)

FDA-Cleared Viscoelastic Testing System Supports Obstetric Bleeding Management

An FDA-cleared viscoelastic test provides rapid point-of-care coagulation insights to guide obstetric bleeding management. More...
08 May 2026
Image: ArteraAI Breast analyzes digitized histopathology images alongside patient clinical variables to produce an AI-derived risk score that provides prognostic insight into the likelihood of distant metastasis (Image credit: Adobe Stock)

FDA Clears AI Digital Pathology Tool for Breast Cancer Risk Stratification

An FDA-cleared AI pathology tool enables same-day metastasis risk stratification in early HR+/HER2- breast cancer to guide care. More...
07 May 2026
Image: Overall workflow of the study. Targeted genes are ITGAM, PECAM1, CCL5, STAT1, STAT2, and CD44. (Dipanwita Nath et al, Cancer Medicine (2026). DOI: 10.1002/cam4.71775)

Inflammatory Gene Signature Links Metabolic Disease to Pancreatic Cancer Recurrence

New data reveal shared inflammatory genes linking pancreatic cancer with obesity/diabetes, enabling better risk stratification. More...
07 May 2026
New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Online QC Software
Acusera 24•7
New
Automated Urinalysis Solution
UN-9000
New
HPV Test
Allplex HPV28 Detection
ADLM